TYVASO DPI
Live / Registered — Registered (as of 13 Sept 2022)
What this means for you
Registered since 13 Sept 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90370386
- Registration number
- 6847625
- Mark type
- Stylized text
- Filed
- 09 Dec 2020
- Published for opposition
- 21 Dec 2021
- Registered
- 13 Sept 2022
- Attorney of record
- Norm J. Rich
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension and interstitial lung disease, and idiopathic pulmonary fibrosis
Owner
- United Therapeutics Corporation, Silver Spring, MD, US
- United Therapeutics Corporation, Silver Spring, MD, US
- United Therapeutics Corporation, Silver Spring, MD, US
Prior registrations
Prosecution history
- 13 Sept 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 Sept 2022 — REGISTERED-PRINCIPAL REGISTER
- 11 Aug 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 10 Aug 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Jun 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jun 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 17 Jun 2022 — USE AMENDMENT FILED
- 27 Jun 2022 — SOU EXTENSION 1 GRANTED
- 17 Jun 2022 — SOU EXTENSION 1 FILED
- 27 Jun 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Jun 2022 — SOU TEAS EXTENSION RECEIVED
- 17 Jun 2022 — TEAS STATEMENT OF USE RECEIVED
- 15 Feb 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 Dec 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Dec 2021 — PUBLISHED FOR OPPOSITION